Stocks and InvestingStocks and Investing
Thu, August 18, 2022
Wed, August 17, 2022
Tue, August 16, 2022
Mon, August 15, 2022

Matthew Harrison Maintained (TSVT) at Buy with Decreased Target to $27 on, Aug 15th, 2022


Published on 2024-10-27 22:39:54 - WOPRAI, Matthew Harrison
  Print publication without navigation


Matthew Harrison of Morgan Stanley, Maintained "2seventy bio, Inc." (TSVT) at Buy with Decreased Target from $28 to $27 on, Aug 15th, 2022.

Matthew has made no other calls on TSVT in the last 4 months.



There is 1 other peer that has a rating on TSVT. Out of the 1 peers that are also analyzing TSVT, 0 agree with Matthew's Rating of Hold.



This is the rating of the analyst that currently disagrees with Matthew


  • Salveen Richter of "Goldman Sachs" Initiated at Strong Buy and Held Target at $26 on, Monday, May 2nd, 2022